STEPHANIE PETRY: Open Payments
NPI 1396054417 · ALLENTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$470 in 26 payments from 11 companies in 2025. Trend: 2023 $484 · 2024 $780 · 2025 $470
Food & beverage: $460Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $144 |
| GENZYME CORPORATION | 2 | $56 |
| Janssen Biotech, Inc. | 2 | $54 |
| UCB, Inc. | 2 | $39 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $35 |
| Galderma Laboratories, L.P. | 2 | $33 |
| Botanix SB Inc | 2 | $32 |
| Lilly USA, LLC | 1 | $27 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $26 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $20 |
Products named: SKYRIZI, DUPIXENT, TREMFYA, Bimzelx, SOFDRA, RINVOQ, EBGLYSS, Cabtreo.
Industry payments across PA — which companies pay providers there.
